NVP-BVU972
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 406788

CAS#: 1185763-69-2

Description: NVP-BVU972, also known as BVN-972, is a selective and potent inhibitor of c-Met with IC50 of 14 nM. BVN-972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON).


Chemical Structure

img
NVP-BVU972
CAS# 1185763-69-2

Theoretical Analysis

MedKoo Cat#: 406788
Name: NVP-BVU972
CAS#: 1185763-69-2
Chemical Formula: C20H16N6
Exact Mass: 340.14
Molecular Weight: 340.390
Elemental Analysis: C, 70.57; H, 4.74; N, 24.69

Price and Availability

Size Price Availability Quantity
25mg USD 250 2 Weeks
50mg USD 750 2 Weeks
100mg USD 1250 2 Weeks
200mg USD 2050 2 Weeks
500mg USD 3650 2 Weeks
1g USD 5250 2 Weeks
2g USD 7850 2 Weeks
Bulk inquiry

Synonym: NVP-BVU972; NVP-BVU 972; NVP-BVU-972; BVU-972; BVU 972; BVU972.

IUPAC/Chemical Name: 6-[[6-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]quinoline

InChi Key: RNCNPRCUHHDYPC-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H16N6/c1-25-13-16(11-23-25)19-6-7-20-22-12-17(26(20)24-19)10-14-4-5-18-15(9-14)3-2-8-21-18/h2-9,11-13H,10H2,1H3

SMILES Code: CN1N=CC(C2=NN3C(C=C2)=NC=C3CC4=CC=C5N=CC=CC5=C4)=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: NVP-BVU972 is an selective and potent Met inhibitor, with an IC50 of 14 nM.
In vitro activity: TBD
In vivo activity: TBD

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 84.0 246.78
Ethanol 68.0 200.00

Preparing Stock Solutions

The following data is based on the product molecular weight 340.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: TBD
In vitro protocol: TBD
In vivo protocol: TBD

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Shin JS, Hong SW, Moon JH, Kim JS, Jung KA, Kim SM, Lee DH, Kim I, Yoon SJ,
Lee CG, Choi EK, Lee JY, Kim KP, Hong YS, Lee JL, Kim B, Choi EK, Lee JS, Jin DH,
Kim TW. NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and
its constitutively active mutants. Invest New Drugs. 2014 Jun;32(3):389-99. doi:
10.1007/s10637-013-0039-4. Epub 2013 Oct 31. PubMed PMID: 24173966.


2: Tiedt R, Degenkolbe E, Furet P, Appleton BA, Wagner S, Schoepfer J, Buck E,
Ruddy DA, Monahan JE, Jones MD, Blank J, Haasen D, Drueckes P, Wartmann M,
McCarthy C, Sellers WR, Hofmann F. A drug resistance screen using a selective MET
inhibitor reveals a spectrum of mutations that partially overlap with activating
mutations found in cancer patients. Cancer Res. 2011 Aug 1;71(15):5255-64. doi:
10.1158/0008-5472.CAN-10-4433. Epub 2011 Jun 22. PubMed PMID: 21697284.